標普和納斯達克內在價值 聯繫我們
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 返回所有股票

Sartorius Stedim Biotech S.A. SRTOY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • FR • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sartorius Stedim Biotech S.A. (SRTOY) 是一家 Medical - Instruments & Supplies 公司，屬於 醫療保健 產業, 目前交易價格為 $21.67. 其SharesGrow評分為 44/100, 表明 一般 的投資特徵， 7項中通過1項.

財務數據: 營收為 $2.9B, -5.9%/yr 平均成長. 淨利潤為 $255M, 成長率為 -20.8%/yr. 淨利潤率為 9% (較薄). 毛利率為 45.3% (-7.2 pp 趨勢).

資產負債表: 總債務為 $2.7B 對比 $4.1B 股東權益 (D/E比率 0.67, 適度). 流動比率為 1.02 (充足). 資產負債率為 34.3%. 總資產: $8.0B.

分析師展望: 0 / 1 位分析師評級 SRTOY 為買入 (0%) — 意見分歧.

SharesGrow 7項標準細分: Value 15/100 (Fail), Growth 15/100 (Fail), Past 100/100 (Pass), Health 50/100 (Partial), Moat 64/100 (Partial), Future 20/100 (Fail), Income 45/100 (Partial).

SRTOY SharesGrow 評分概覽

44/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
價值 15/100
估值 — P/E, PEG, Forward PEG
成長 15/100
財務數據 — 平均成長
過去 100/100
強勁 — 趨勢
健康 50/100
資產負債表 — D/E比率, 流動比率為
護城河 64/100
毛利率為 + market cap
未來 20/100
分析師展望 — 為買入
收入 45/100
淨利潤率為
Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — SRTOY

✗
價值 Fail
15/100
SRTOY 本益比(P/E)為 N/A (S&P 500平均約25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
成長 Fail
15/100
SRTOY: -5.9%/yr 營收為, -20.8%/yr 淨利潤為 平均成長. 較弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
過去 Pass
100/100
SRTOY: 4 / 4 年獲利. 強勁 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
健康 Partial
50/100
資產負債表 SRTOY: D/E比率 0.67 (適度), 流動比率為 1.02 (充足). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
護城河 Partial
64/100
SRTOY: 毛利率為 45.3% (-7.2 pp 趨勢), $211B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 64/100. ≥ 70 = Pass.
View details →
✗
未來 Fail
20/100
分析師展望: 0 / 1 位分析師評級 SRTOY 為買入 (0%). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.
View details →
~
收入 Partial
45/100
SRTOY: 淨利潤率為 9%. 較薄 (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

市場數據
52週區間17.395-26.54
成交量8.51K
30日平均成交量111.58K
市值$210.8B
Beta（1年）1.17
股息率$0.0451
Share Statistics
EPS（TTM）0.03
流通股數$9.73B
IPO Date2022-02-09
Employees9,961
CEORene Faber
Financial Highlights & Ratios
Revenue (TTM)$2.85B
Gross Profit$1.29B
EBITDA$832.88M
Net Income$255.12M
Operating Income$527.33M
Total Cash$425.92M
Total Debt$2.75B
Net Debt$2.32B
Total Assets$8.01B
Price / Earnings (P/E)833.5
Price / Sales (P/S)73.96
Analyst Forecast
評級共識Hold
覆蓋分析師數1
買入 0% 持有 100% 賣出 0%
公司資訊
國家FR
交易所Other OTC
貨幣USD
ISINUS80386Y1010

股價走勢

Track all markets on TradingView
SRTOY
Sartorius Stedim Biotech S.A. ↗  ·  Other OTC
Healthcare • Medical - Instruments & Supplies
17.40 52WK RANGE 26.54

其他人也在看

BDX
BDX
Becton, Dickinson and Company
$155.73
+0.19%
 ALC
ALC
Alcon Inc.
$79.94
+0.25%
 RMD
RMD
ResMed Inc.
$230.69
+0.19%
 WST
WST
West Pharmaceutical Services, Inc.
$267.93
+3.07%
 HOLX
HOLX
Hologic, Inc.
$76.01
+0.00%
 COO
COO
The Cooper Companies, Inc.
$71.61
-0.13%
 BAX
BAX
Baxter International Inc.
$17.59
-0.23%
 TFX
TFX
Teleflex Incorporated
$125.21
+1.65%
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值，發現被低估的股票。
每週線上課程
📧 [email protected]
📞 +65 8912 8000
給我們留言